Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greyrock Capital Group is a private investment firm that provides mezzanine debt and equity capital to lower middle-market companies. Established in 2002, the firm focuses on supporting management buyouts, leveraged buyouts, recapitalizations, and growth capital needs. While they are a generalist firm, they have a history of investing in sectors such as healthcare services, industrial manufacturing, and consumer products. Greyrock typically targets companies with consistent cash flow and strong management teams, providing flexible capital solutions ranging from $5 million to $35 million per transaction. The firm maintains a presence across the United States with offices in San Francisco, Los Angeles, and Chicago.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greyrock Capital Group.